If a threshold of 10% risk of COPD was used to make spirometry referrals, the addition of the polygenic risk score correctly ...

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...

The following is a summary of “Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and ...

About 10% of Sri Lankans over the age of 40 are affected by Chronic Obstructive Pulmonary Disease (COPD), a condition often linked to smoking, prolonged exposure to air pollution, or untreated asthma, ...

Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before death, with some medications tied to higher fall risk, according to a study published ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

People with lung conditions such as asthma, COPD, and emphysema need to be particularly careful in the cold because breathing in cold air can constrict airway muscles making it harder to breathe, so ...